Y Intercept Hong Kong Ltd increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 351.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,368 shares of the real estate investment trust's stock after buying an additional 32,982 shares during the period. Y Intercept Hong Kong Ltd's holdings in Omega Healthcare Investors were worth $1,857,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in OHI. Norges Bank bought a new position in shares of Omega Healthcare Investors in the fourth quarter worth about $156,166,000. Invesco Ltd. grew its stake in shares of Omega Healthcare Investors by 101.7% during the third quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust's stock valued at $208,775,000 after purchasing an additional 2,493,877 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Omega Healthcare Investors in the fourth quarter valued at approximately $93,476,000. Cbre Investment Management Listed Real Assets LLC increased its holdings in shares of Omega Healthcare Investors by 327.5% in the fourth quarter. Cbre Investment Management Listed Real Assets LLC now owns 2,222,799 shares of the real estate investment trust's stock valued at $98,559,000 after purchasing an additional 1,702,846 shares in the last quarter. Finally, Daiwa Securities Group Inc. raised its position in Omega Healthcare Investors by 84.6% in the 3rd quarter. Daiwa Securities Group Inc. now owns 3,058,031 shares of the real estate investment trust's stock worth $129,110,000 after purchasing an additional 1,401,066 shares during the last quarter. Institutional investors own 65.25% of the company's stock.
Omega Healthcare Investors Trading Down 1.0%
NYSE OHI opened at $48.86 on Friday. The firm has a market cap of $14.55 billion, a P/E ratio of 23.60, a P/E/G ratio of 2.10 and a beta of 0.58. The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. The stock's 50-day moving average is $46.90 and its 200-day moving average is $46.03. Omega Healthcare Investors, Inc. has a one year low of $35.70 and a one year high of $50.10.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The business had revenue of $322.95 million during the quarter, compared to analyst estimates of $264.07 million. During the same quarter in the prior year, the firm posted $0.75 earnings per share. Omega Healthcare Investors's revenue for the quarter was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 3.1 earnings per share for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 5.5%. The ex-dividend date was Monday, May 4th. Omega Healthcare Investors's dividend payout ratio is 129.47%.
Wall Street Analyst Weigh In
Several research firms have issued reports on OHI. UBS Group set a $47.00 price objective on Omega Healthcare Investors in a report on Thursday, June 18th. Royal Bank Of Canada lifted their target price on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a "sector perform" rating in a research note on Monday, May 4th. Scotiabank dropped their target price on Omega Healthcare Investors from $50.00 to $47.00 and set a "sector perform" rating for the company in a research report on Thursday, June 18th. Truist Financial cut their price target on Omega Healthcare Investors from $48.00 to $46.00 and set a "hold" rating on the stock in a research note on Tuesday, June 9th. Finally, Barclays began coverage on Omega Healthcare Investors in a report on Tuesday. They issued an "underweight" rating and a $51.00 price target on the stock. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $48.50.
View Our Latest Stock Analysis on OHI
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.